TScan Therapeutics
proprietary platform enables identification of the natural targets of for therapy defined targets | TScan Therapeutics
Company
Deck Type
IPO
Sector
Industry
Deck date
July 2021
Slide
13 of 43
Related slides by other companies
Immix Biopharma
Investor Presentation
November 2023
genius technology platform proprietary cobra binding domain is a differentiated innovation | Immix Biopharma
Oak Street Health
Investor Day
April 2022
| Oak Street Health
GitLab
Investor Presentation
December 2023
a platform enables end to end governance | GitLab
Cano Health
Results
August 2021
platform enables strong clinical outcomes guides provider resulting | Cano Health
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights